Prices delayed by at least 15 minutes | Print


Elevance Health (ELV)

Common Stock
Sell: $500|Buy: $558.03|Change: 6.24 (1.18%)

Open 

$532.4


Previous close 

$529.93


Trade high 

$536.89


Volume 

692,867


Year high 

$542.07


Year low 

$412.00


Dividend yield 

1.15%


Market capitalisation 

$124.62 bn


P/E ratio 

19.99


ISIN 

US0367521038


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Dividends

PreviousLatest
Record date08/03/202410/06/2024
Ex-dividend date07/03/202410/06/2024
Payment date22/03/202425/06/2024
Amount$1.63$1.63

Performance 07/05/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Elevance Health+ 1.18
More...

Company profile

Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 47 million medical members as of December 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as theAmerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.